Protagonist Therapeutics Inc (PTGX)
US$ 52.53-0.23%
Price Chart
Key Statistics
Market Cap
$ 3.29B
P/E Ratio
67.95
Revenue (TTM)
$ 207.8M
Volume
1.52M
52W High
$ 60.60
52W Low
$ 32.50
Dividend Yield
0.00%
Beta
2.25
Technicals
50-Day MA
49.7408
200-Day MA
44.8153
52 Week High
60.6
52 Week Low
32.5
About PTGX
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
Employees
124
Headquarters
Newark, CA
CEO
Dr. Dinesh V. Patel Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg